Sector
PharmaceuticalsOpen
₹268.5Prev. Close
₹269.9Turnover(Lac.)
₹0.84Day's High
₹269.9Day's Low
₹26552 Week's High
₹417.8552 Week's Low
₹245Book Value
₹108.02Face Value
₹10Mkt Cap (₹ Cr.)
154.92P/E
15.94EPS
16.93Divi. Yield
1.675 Feb 2025
12:00 AM
Board Meeting
Agenda : Audited Result
18 May 2024
12:00 AM
AGM
Announcement Date: 18 May, 2024
18 May 2024
12:00 AM
Dividend
Dividend Amount: 4.5
Record Date: 02 Aug, 2024
16 Jul 2024
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 5.76 | 5.76 | 5.76 | 5.94 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 56.4 | 48.94 | 42.83 | 37.13 |
Net Worth | 62.16 | 54.7 | 48.59 | 43.07 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 69.39 | 57.45 | 59.47 | 41.01 |
yoy growth (%) | 20.78 | -3.4 | 45.02 | -6.1 |
Raw materials | -48.97 | -37.18 | -36.15 | -24.04 |
As % of sales | 70.57 | 64.71 | 60.78 | 58.62 |
Employee costs | -6.61 | -6.25 | -7.49 | -6.25 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 9.1 | 8.74 | 8.12 | 5.17 |
Depreciation | -0.63 | -0.78 | -0.96 | -0.75 |
Tax paid | -2.33 | -2.38 | -2.17 | -1.41 |
Working capital | -0.33 | 4.99 | 9.66 | 1.37 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 20.78 | -3.4 | 45.02 | -6.1 |
Op profit growth | 6.64 | -5.14 | 67.27 | 11.67 |
EBIT growth | 3.34 | 2.47 | 62.25 | 1.81 |
Net profit growth | 13.58 | 7.01 | 57.84 | 12.83 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,744.85 | 132.89 | 4,18,647.96 | 1,181.05 | 0.77 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,001.1 | 76.85 | 1,59,310.35 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,478.5 | 25.66 | 1,19,409.63 | 1,438.15 | 0.88 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,137.55 | 58.21 | 1,06,184.18 | 485 | 0.89 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,413.35 | 51.49 | 99,569.64 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairperson & Managing Direct
Jayashree Nair
Joint Managing Director & CFO
S C Kachhara
Non Executive Director
Karthika Nair
Company Sec. & Compli. Officer
Nikita Phatak
Independent Director
Prabhakar Dalal
Independent Director
Mitul Patel
Independent Director
Suresh Chandra Kookada
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by BDH Industries Ltd
Summary
Incorporated in 1990 as a private limited company, BDH Industries (BDHIL) was converted into a public limited company in 1994. It was established to take over a going concern, Bombay Drug House Pvt Ltd. This company was amalgamated with BDHIL in 1994 and, since then, it has been manufacturing a wide range of drug formulations in the antibiotic, anti-inflamatory and anti-microbial segments.The Company is engaged in manufacturing of therapeutic formulations covering wide range of pharmaceuticals.BDH offers a full range of Oral Solid Dosages (OSD) technologies. Our research And development centre at Kandivali, Mumbai, is equipped to undertake formulation development projects on new Novel Drug Delivery System (NDDS).It came out with a public issue in Feb.95, aggregating Rs 6.10 cr to modernise and expand its production facilities and to augment long-term working capital. BDHIL has entered into a MoU with the Nepothene Group Pvt Ltd, Nepal, to provide assistance in setting up a pharmaceutical company there. The expansion-cum-modernisation project commenced commercial production from May, 1999.During the year 2000-2001 the company has taken up expansion and modernisation project and the project has been financed by Term Loan from Banks. The company has repaid Rs.152.21 lacs of Term Loan.The Company commissioned two units of wind turbines 0.8 MW each at Jaisalmer Dist., in Rajasthan. It ventured into agro products business in 2021-22.
Read More
What is the BDH Industries Ltd share price today?
The BDH Industries Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹268.95 today.
What is the Market Cap of BDH Industries Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of BDH Industries Ltd is ₹154.92 Cr. as of 09 May ‘25
What is the PE and PB ratio of BDH Industries Ltd?
The PE and PB ratios of BDH Industries Ltd is 15.94 and 2.50 as of 09 May ‘25
What is the 52 Week High and Low of BDH Industries Ltd?
The 52-week high/low is the highest and lowest price at which a BDH Industries Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of BDH Industries Ltd is ₹245 and ₹417.85 as of 09 May ‘25
What is the CAGR of BDH Industries Ltd?
BDH Industries Ltd's CAGR for 5 Years at 34.31%, 3 Years at 28.33%, 1 Year at -21.88%, 6 Month at -16.95%, 3 Month at -16.43% and 1 Month at 0.33%.
What is the shareholding pattern of BDH Industries Ltd?
The shareholding pattern of BDH Industries Ltd is as follows:
Promoters - 49.66 %
Institutions - 0.28 %
Public - 50.06 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
